| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/11/2010 | WO2010015090A1 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 02/11/2010 | US20100037328 Cd20-negatively converted b cell malignant lymphocyte cell line and utilization of the same |
| 02/11/2010 | US20100034751 Dehydrated granular composition and biomedical applications thereof |
| 02/11/2010 | US20100034750 Composition and method for detection of demineralisation |
| 02/11/2010 | US20100034749 Use of a Cationic Collodal Preparation for the Diagnosis and Treatment of Ocular Diseases |
| 02/11/2010 | US20100034748 Molecular imaging probes based on loaded reactive nano-scale latex |
| 02/11/2010 | US20100034747 Detection of HIV-1 Infection |
| 02/11/2010 | US20100034746 Animal model, system, and method for screening compounds for antithrombotic and/or thrombolytic activity |
| 02/11/2010 | US20100034745 Method for Reducing Levels of Disease Associated Proteins |
| 02/11/2010 | US20100034744 Method For Screening Anti-HIV Drugs and A Diagnostic Method of AIDS |
| 02/11/2010 | US20100034743 Raman Characterization of Transplant Tissue |
| 02/11/2010 | US20100034742 Modular monolayer coatings for selective attachment of nanoparticles to biomolecules |
| 02/11/2010 | US20100034739 Fungus-Specific Imaging Agents |
| 02/11/2010 | US20100034738 Structural Variants of Antibodies for Improved Therapeutic Characteristics |
| 02/11/2010 | US20100034735 Targeted nanoparticles for cancer diagnosis and treatment |
| 02/11/2010 | CA2733442A1 Carbon nanotube based magnetic resonance imaging contrast agents |
| 02/10/2010 | EP2151249A1 PH-sensitive probe comprising polymer and fluorescent dye |
| 02/10/2010 | EP2150278A1 Novel photosensitizer based on polymer derivatives-photosensitizer conjugates for photodynamic therapy |
| 02/10/2010 | CN101646465A Methods and compositions for treating il-4 or il-13 related fibrosis related pathologies |
| 02/10/2010 | CN101642579A Chitosan modified paramagnetic metal ion magnetic resonance imaging contrast agent preparation method |
| 02/10/2010 | CN101642578A Method for determining inhibitory activity of porphyra yezoensis ueda phycobiliprotein sarcoma |
| 02/09/2010 | US7659243 Treatment of ALS and variants thereof consisting of primary lateral sclerosis (PLS) or spinal muscular atrophy (SMA) |
| 02/09/2010 | US7659057 Using toluidine blue O (TBO) dye to detect precancerous cells; histological staining and tumor detection |
| 02/09/2010 | US7658913 Compositions useful for reducing nephrotoxicity and methods of use thereof |
| 02/09/2010 | US7658912 Administering test compound to subjects and having them perform a sustained task; evaluation, data processing, drug screening; Alzheimer*s disease, Parkinson*s disease, schizophrenia; nervous system disorders; magnetic resonance imaging |
| 02/09/2010 | US7658911 Measuring the level of NR2A and/or NR2B NMDA receptor within three hours after stroke onset; for diagnosing stroke in an emergency room setting |
| 02/09/2010 | CA2466372C Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 02/09/2010 | CA2387503C Fluorescent cobalamins and uses thereof |
| 02/09/2010 | CA2370714C Bacterial ghosts as carrier and targeting vehicles |
| 02/09/2010 | CA2294274C Compositions and methods for reversibly increasing permeability of biomembranes |
| 02/06/2010 | CA2660507A1 Targeted nanoparticles for cancer diagnosis and treatment |
| 02/04/2010 | WO2010013235A2 Breath test device and method |
| 02/04/2010 | WO2010013137A1 Active particles for bio-analytical applications and methods for preparation thereof |
| 02/04/2010 | WO2010013136A2 Active particles for bio-analytical applications and methods for their preparation |
| 02/04/2010 | WO2010012473A2 Hydrolase-specific nanosensors, methods for producing them and uses in molecular imaging |
| 02/04/2010 | WO2009134435A3 Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications |
| 02/04/2010 | WO2009016180A3 Peptide imaging agents |
| 02/04/2010 | WO2003063798A9 Compositions and methods for treatment of infectious and inflammatory diseases |
| 02/04/2010 | US20100031379 Non-human animal for eye disease model |
| 02/04/2010 | US20100031377 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 02/04/2010 | US20100029922 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes |
| 02/04/2010 | US20100029920 Method for assessing the effect of a drug on long term memory formation |
| 02/04/2010 | US20100029908 Absorbable sponge with contrasting agent |
| 02/04/2010 | US20100028327 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/04/2010 | US20100028264 Ltbp2 as a biomarker, therapeutic and diagnostic target |
| 02/04/2010 | US20100028263 Methods for inhibiting mast cell activation and treating mast cell-dependent inflammatory diseases and disorders using lactobacillus |
| 02/04/2010 | US20100028262 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 02/04/2010 | US20100028261 Molecular Specific Photoacoustic Imaging |
| 02/04/2010 | US20100028260 Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods |
| 02/04/2010 | US20100028259 Use of organic cation transporters for cancer diagnosis and therapy |
| 02/04/2010 | CA2732342A1 Breath test device and method |
| 02/04/2010 | CA2730015A1 Immunoassay for detection of neurotoxic amino acid associated with neurological disorders |
| 02/03/2010 | EP2149105A1 A method for counting and segmenting viral particles in an image |
| 02/03/2010 | EP2148881A1 Fluorinated lanthanide probes for 19f magnetic resonance applications |
| 02/03/2010 | EP2148702A2 Pentamethine cyanine dyes carrying at least three sulfonic acid groups |
| 02/03/2010 | EP2148701A2 Imaging contrast agents using nanoparticles |
| 02/03/2010 | EP2148675A1 Anti-cancer medicine both for diagnosing and treating cancer |
| 02/03/2010 | CN101641119A Contrast agents |
| 02/03/2010 | CN101637613A Lipid targeted ultrasound contrast agent and preparation method thereof |
| 02/03/2010 | CN101637612A Respiratory-tract magnetic-resonance spray contrast agent and preparation method thereof |
| 02/03/2010 | CN100586482C Lymph dye with silicon dioxide microparticle as supporter and its preparation method |
| 02/02/2010 | US7655218 Methods and compositions for detection and diagnosis of infectious diseases |
| 02/02/2010 | US7655217 Using water soluble dyes; fluorescence contrast agent |
| 02/02/2010 | US7655216 nontarget antigen to sensitize a patient's CD8+ T cells followed with administration of a vaccine comprising a target antigen (such as a tumor-associated antigen or a pathogen-associated antigen); cancer and autoimmune diseases |
| 02/02/2010 | CA2426043C Modulating angiogenesis |
| 02/02/2010 | CA2407520C Sigma-2 receptors as biomarkers of tumor cell proliferation |
| 02/02/2010 | CA2230885C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/28/2010 | WO2010011856A2 Stereospecificity of methylsulfinyl reduction |
| 01/28/2010 | WO2010011154A1 Methods for identifying biomarkers, therapies and compounds suitable for the treatment of depression and schizophrenia and pharmaceutical compositions thereof and development of drugs targeting a newly discovered cns arachidonic acid pathway of anhedonia |
| 01/28/2010 | WO2010010079A1 Diagnostic agents selective against metalloproteases |
| 01/28/2010 | WO2009009786A3 Magneto-motive ultrasound detection of magnetic nanoparticles |
| 01/28/2010 | US20100022872 Method and apparatus for 3-d imaging of internal light sources |
| 01/28/2010 | US20100021394 High penetration prodrug compositions of 1h-imidazo[4,5-c]quinolin-4-amines and 1h-imidazo[4,5-c]quinolin-4-amine-related compounds |
| 01/28/2010 | US20100021391 Novel nanoparticles for biofilm targeting |
| 01/28/2010 | US20100021390 Fluorescent Analogs Of The Islet Amyloid Polypeptide |
| 01/28/2010 | US20100021389 Radiographic contrast agent for postmortem, experimental and diagnostic angiography |
| 01/28/2010 | US20100021388 Benzothiazole derivative compounds, compositions and uses |
| 01/28/2010 | US20100021387 Methods for Inducing Reversible Stasis |
| 01/28/2010 | US20100021386 Treatment, prevention,and reversal of alcohol-induced liver disease |
| 01/28/2010 | US20100021385 Benzoxazole derivatives |
| 01/28/2010 | US20100021384 Use of vhh antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications |
| 01/28/2010 | US20100021383 Molecular probe for sphingolipids |
| 01/28/2010 | US20100021382 Pyrazine Derivatives and Uses Thereof |
| 01/28/2010 | US20100021379 Chemical Antibodies for Immunotherapy and Imaging |
| 01/28/2010 | DE19714167B4 Gerät zum Zuführen von Behandlungsmedium in Hartgewebe und Verwendung eines solchen Device for feeding in treatment medium hard tissue and use of such a |
| 01/27/2010 | EP2147684A1 Diagnostic Agents Selective Against Metalloproteases |
| 01/27/2010 | EP2146753A2 18f fluoro-benzoyl labelled biological active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl , 2,5-dioxo-pyrrolidin-1-yloxy)benzoyl and trimethylammonio-benzoyl precursers thereof |
| 01/27/2010 | EP2146749A2 Labelled hgf binding peptides for imaging |
| 01/27/2010 | CN100584378C Use of mycobacterium antigen MPB64 in preparing product for locally detecting active tuberculosis |
| 01/26/2010 | US7653429 Techniques for identifying molecular structures and treating cell types lining a body lumen using fluorescence |
| 01/26/2010 | US7652191 Post-traumatic stress disorder (PTSD)-like behavior include re-experiencing a trauma in response to a stimulus associated with the trauma, avoidance of social interaction; and hyper-arousal in response to a stimulus not associated with the trauma; Drug screening; post-traumatic stress disorder (PTSD) |
| 01/26/2010 | US7651679 N-terminal-pro brain natriuretic peptides |
| 01/26/2010 | CA2222524C Somatostatin peptides |
| 01/21/2010 | WO2010008876A2 Method for preparation of micellar hybrid nanoparticles for therapeutic and diagnostic applications and compositions thereof |
| 01/21/2010 | WO2010008519A2 In vitro diagnostic markers comprising carbon nanoparticles and kits |
| 01/21/2010 | WO2010008478A2 Improved techniques for magnetic particle imaging |
| 01/21/2010 | WO2010008001A1 Aptamer against il-17 and use thereof |
| 01/21/2010 | WO2010007803A1 Nanoparticle labeling and system using the nanoparticle labeling |
| 01/21/2010 | WO2010007329A2 Novel method for measuring insulin resistance |
| 01/21/2010 | WO2010006703A1 G-protein coupled receptor 30 (gpr30) knockout mice as a model for cardiovascular diseases |